Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Radiologists often mistake these bony lesions near the knee as more serious conditions, such as cancer, but researchers say such irregularities are typically benign.
Lead researcher Majid Fotuhi, MD, PhD, also said that completing a baseline MRI before these patients leave the hospital is “imperative" to their future treatment.
The approach was on-par with CT scan quality at detecting some of the most common findings associated with the disease, including lesions and ground-glass opacities, experts wrote in the Journal of MRI.
COVID-19 can show up incidentally when a patient’s lungs are partially readable on CT scans of the abdomen or neck. And the findings can help identify patients who should be strictly quarantined.
The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.
CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.